AYURVEDIC MANAGEMENT IN MIGRAINE

EVALUATION OF THE EFFECT OF PRAPAUNDARIKADI TAILA WITH VARUNADI KASHAYA ON THE SERUM CALCITONIN GENE-RELATED PEPTIDE IN ARDHAVABHEDAKA(MIGRAINE) - AN OPEN LABEL SINGLE ARM CLINICAL STUDY - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055769

Enrollment

Registered

2023-07-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects of either gender irrespective of religion, race, occupation presenting with signs and symptoms of Ardhavabhedaka (Migraine). 2.Subjects who are 18yrs-65yrs willing to participate for treatment. 3.Subjects who fit for Nasya karma.

Exclusion criteria

Exclusion criteria: 1.Subjects with referred pain in one half of head due to disorders of eye, ear, nose and teeth. 2.Subjects with uncontrolled Diabetes Mellitus, Hypertension, Thyroid dysfunction and other systemic illness. 3.Other type of headache such as Tension-type headache, Cluster headache. ? Pregnant women and lactating mothers.

Design outcomes

Primary

Measure	Time frame
To know the level of Calcitonin Gene-related peptide in serumTimepoint: BT- 0th day AT - 45th day	—

Secondary

Measure	Time frame
To assess the signs & symptoms of MigraineTimepoint: BT - 0th Day AT - 45th Day	—

Countries

India

Contacts

Public ContactDr Gavimath Shivanand

JSS Ayurveda Medical College and Hospital, Mysuru

Shiva.shalakya@gmail.com9448211075

Outcome results